Adhesion Barrier Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Synthetic Adhesion Barriers (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, Others), Natural Adhesion Barrier (Collagen & Protein, Fibrin )), By Formulation (Film/Mesh, Gel, Liquid), By Application (Gynecological Surgeries, Abdominal General Surgeries, Orthopedic Surgeries, Cardiovascular Surgeries, Neurological Surgeries, Urological Surgeries, Others), By Region, Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 724.89 million

CAGR (2023-2028)

5.54%

Fastest Growing Segment

Synthetic adhesion barrier segment

Largest Market

North America

Market Overview

Global Adhesion Barrier Market has valued at USD 724.89 million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.54% through 2028. An adhesion barrier is a medical device used in surgery to prevent the formation of adhesions between tissues and organs. Adhesions are bands of scar tissue that can develop after surgical procedures, injury, or inflammation. These adhesions can cause tissues that are not normally connected to become bound together, potentially leading to complications and discomfort for the patient. Adhesion barriers are designed to create a physical barrier between tissues during the healing process after surgery. This barrier helps prevent the adhesion of tissues that can lead to complications such as pain, bowel obstruction, infertility, and other issues. Adhesion barriers are typically made from biocompatible materials that are safe for use within the body. The primary goal of using adhesion barriers is to improve patient outcomes by reducing the risk of complications associated with post-operative adhesions. Adhesion barriers can contribute to shorter hospital stays, faster recovery times, and fewer readmissions due to complications. The trend towards minimally invasive surgical approaches requires adhesion barriers that can be applied through smaller incisions while still effectively preventing adhesions. As these techniques become more popular, the demand for compatible adhesion barriers grows. The global aging population is a significant driver of surgical procedures, especially those associated with age-related conditions. This demographic trend contributes to the demand for adhesion barriers. Hospitals and healthcare providers are increasingly focused on reducing post-operative complications to improve patient satisfaction and minimize additional healthcare costs. Adhesion barriers play a role in achieving this objective.

Key Market Drivers

Growing Global Aging Population

 As the world's population continues to age, there is an increased prevalence of age-related medical conditions that require surgical interventions. Older individuals are more likely to undergo surgeries, including procedures such as abdominal, gynecological, and orthopedic surgeries. These surgeries often involve higher risks of post-operative adhesions due to changes in tissue healing and repair mechanisms that occur with age. Age-related changes in tissue elasticity, blood circulation, and immune response can increase the likelihood of post-operative adhesions. Adhesion barriers are used to reduce these risks and prevent complications in older patients. The aging population often requires more complex surgeries, such as joint replacements, hernia repairs, and cardiovascular procedures. These complex surgeries may involve larger incisions and a higher risk of adhesions, making the use of adhesion barriers crucial. Older patients may have slower recovery rates and a greater susceptibility to complications. Adhesion barriers can help improve the recovery process by minimizing the risk of adhesions and related complications. Many older individuals prioritize maintaining their quality of life and independence. Minimizing the risk of post-operative complications using adhesion barriers aligns with these goals. The aging population often prefers to avoid additional surgeries or medical interventions due to increased health risks. Adhesion barriers can contribute to reducing the need for secondary surgeries related to adhesion complications. Healthcare systems and providers are increasingly focused on providing personalized and effective care to the aging population. Adhesion barriers are part of this effort to optimize patient outcomes. The economic burden of post-operative complications on healthcare systems is significant. By using adhesion barriers to prevent complications, healthcare costs can be reduced, aligning with efforts to manage healthcare spending. This factor will help in the development of the Global Adhesion Barrier Market.

Increasing Adhesion-Related Complications

Adhesion-related complications refer to medical issues that arise due to the formation of adhesions within the body. Adhesions are bands of scar tissue that form between tissues and organs, often because of surgical procedures, injury, or inflammation. These adhesions can cause tissues that are not normally connected to become bound together. Adhesion-related complications can lead to a range of symptoms and health problems, depending on their location and severity. It can form after surgical procedures as part of the body's natural healing process. They can also develop because of infections, inflammation, trauma, or radiation therapy. It can also occur in various parts of the body, such as the abdominal cavity, pelvis, joints, and even internal organs. In the context of surgical procedures, abdominal and pelvic adhesions are particularly common. Adhesion can lead to chronic pain in the affected area. In the abdominal cavity, adhesion can cause the intestines to become twisted or blocked, leading to bowel obstruction and severe pain. Pelvic adhesions can affect reproductive organs and lead to fertility problems. Adhesions can make subsequent surgeries more difficult and increase the risk of injury to surrounding tissues and organs and Adhesions around joints can restrict movement and cause discomfort. symptoms of adhesion-related complications vary depending on the location and severity of the adhesions. Common symptoms include abdominal pain, bloating, changes in bowel habits, infertility, and difficulty moving certain body parts. Adhesion prevention is an essential consideration in surgical procedures. Surgeons may use adhesion barriers, such as films, meshes, or gel-like substances, to create a physical barrier between tissues and prevent the formation of adhesions during the healing process. Treatment options for adhesion-related complications depend on the specific issue. Conservative approaches may include pain management and dietary adjustments for bowel-related issues. Surgical interventions may be required to remove adhesions in cases of severe complications. Adhesion-related complications are important to consider when planning and performing surgical procedures. Surgeons take precautions to minimize the risk of adhesions and address them promptly if they occur. Medical researchers and companies are continuously working on developing improved methods for preventing and managing adhesion-related complications. This includes the development of advanced adhesion barriers and minimally invasive techniques. This factor will pace up the demand of the Global Adhesion Barrier Market.

Rising Demand of Minimally Invasive Procedures

Minimally invasive surgical techniques, also known as minimally invasive surgery (MIS), involve performing surgical procedures with smaller incisions compared to traditional open surgery. In Minimally invasive surgery specialized instruments are inserted to perform the procedure. While these smaller incisions are associated with less tissue trauma compared to traditional open surgery, they still pose a risk of tissue adhesion. Adhesion barriers are used to create a barrier between tissues and organs, preventing them from sticking together as they heal. These techniques utilize specialized instruments, cameras, and advanced imaging technology to visualize and access the surgical site. Adhesion barriers are designed to be easily introduced through small incisions. This is essential for minimally invasive surgery, where the size of the incision is a key factor in reducing patient discomfort and promoting quicker recovery. In laparoscopic surgery, a few small incisions are made in the abdomen, through which specialized instruments and a camera (laparoscope) are inserted. The surgeon views the surgical site on a monitor and performs the procedure using these instruments. Robot-assisted surgery involves a robotic system controlled by the surgeon. The surgeon operates from a console, manipulating robotic arms with precision. This approach is often used for complex procedures that require high precision. Endoscopic procedures involve the insertion of a thin, flexible tube (endoscope) with a camera and light source through small incisions or natural body openings. This allows the surgeon to visualize and operate internally without larger incisions. Arthroscopy is used for joint-related procedures. A small incision is made near the joint, and an arthroscope is inserted to visualize the joint's interior. Instruments can be introduced through additional small incisions for repairs. Minimally invasive techniques result in smaller incisions compared to traditional open surgery, leading to reduced scarring and less tissue trauma. Patients often experience less post-operative pain and discomfort, as the trauma to surrounding tissues is minimized. Recovery times are typically shorter, allowing patients to return to their normal activities more quickly. The risk of blood loss is generally lower due to the smaller incisions and precise visualization. Smaller incisions and reduced exposure of internal tissues can lead to a lower risk of infection. In many cases, patients require shorter hospital stays, leading to cost savings and less disruption to daily life. This factor will accelerate the demand of the Global Adhesion Barrier Market.

Download Free Sample Report

Key Market Challenges

Efficacy and Longevity

The effectiveness of adhesion barriers in preventing adhesions and their ability to maintain their performance over time are critical factors for their successful adoption and use. Adhesion barriers are designed to prevent the formation of adhesions between tissues, which can cause complications and lead to various health issues. Ensuring that adhesion barriers effectively fulfill their intended purpose is of utmost importance. Patients can respond differently to adhesion barriers due to factors such as their health status, genetics, and surgical history. This variability in response can impact the overall effectiveness of the barrier. The complexity of surgical procedures can influence the efficacy of adhesion barriers. More complex surgeries might pose challenges in proper barrier placement or adherence, affecting their performance. The location of the surgery and the type of tissues involved can impact the barrier's effectiveness. Some surgical sites may be more prone to adhesion than others. Adhesion barriers are meant to prevent adhesions during the critical healing phase after surgery. Ensuring that they remain effective throughout the entire healing process is essential to prevent late-onset complications. Some adhesion barriers are designed to degrade or be absorbed by the body over time. Balancing material degradation with the barrier's effectiveness and durability can be challenging.

Adverse Events and Side Effects

Indeed, adverse events and side effects are significant challenges in the global adhesion barrier market. Adhesion barriers, like any medical intervention, can potentially lead to unwanted reactions or complications. Managing and minimizing adverse events and side effects is crucial for the successful adoption and utilization of adhesion barrier products. Adverse events refer to any unexpected and undesirable outcome associated with the use of a medical product. The use of foreign materials can increase the risk of infections at the surgical site. Some patients may experience an inflammatory response to the adhesion barrier material. Allergic reactions to certain materials can lead to discomfort and complications. Adhesion barriers might move from their intended position, potentially causing issues in surrounding tissues. In rare cases, the adhesion barrier material itself could cause obstruction or other complications. The presence of foreign materials, such as adhesion barriers, within the body can trigger various reactions. The body's response to these materials can vary, and in some cases, it might lead to inflammation or other undesirable effects. Adhesion barrier materials need to be carefully selected to ensure they are biocompatible with the patient's body. Incompatibility can lead to adverse reactions, complications, and suboptimal healing. Patients have unique medical histories, genetic backgrounds, and responses to treatment. This clinical variability can contribute to variations in how patients react to adhesion barriers.

Key Market Trends

Advancements in Material Science

Modern materials are designed to interact harmoniously with the body's tissues, minimizing the risk of adverse reactions, inflammation, or rejection. Improved biocompatibility leads to better patient outcomes and reduced complications. Advanced materials are developed to maintain their properties and effectiveness over an extended period. This is crucial for preventing adhesions during the critical healing phase after surgery. Researchers can engineer materials with specific mechanical properties, such as flexibility, elasticity, and strength, to match the requirements of different surgical procedures and anatomical sites. Some adhesion barriers are designed to be absorbed or resorbed by the body over time. Advanced materials enable controlled degradation, ensuring that the barrier's function is fulfilled during the critical healing phase. Hybrid materials or composite structures can be created by combining different materials to optimize adhesion barrier performance. These combinations can offer a balance of attributes like flexibility, strength, and biocompatibility. Some advanced adhesion barrier materials can incorporate drug delivery capabilities, releasing medications directly at the surgical site to further reduce inflammation, pain, or the risk of adhesion formation. Materials can be designed to encourage tissue healing and regeneration. Bioactive components can enhance the integration of the barrier with surrounding tissues. Adhesion barrier materials must undergo rigorous testing and clinical validation to demonstrate their safety and effectiveness in preventing adhesions. The field of material science is continuously evolving, leading to a steady stream of new materials with improved properties. This encourages ongoing innovation in the development of adhesion barrier products.

Segmental Insights

Product Insights

In 2022, the Global Adhesion Barrier was dominated by the Synthetic adhesion barrier and is predicted to continue expanding over the coming years. Synthetic adhesion barriers have benefitted from continuous advancements in material science. These advancements have led to the development of synthetic materials that offer improved biocompatibility, reduced risks of adverse reactions, and longer-lasting effectiveness. Synthetic adhesion barriers can be engineered to have specific properties that are tailored to the needs of different surgical procedures. Their versatility in terms of formulation and design can make them suitable for a wide range of surgeries. Surgeons and healthcare professionals may prefer products that offer reliable outcomes.

Formulation Insights

In 2022, the Global Adhesion Barrier was dominated by film/mesh segment and is predicted to continue expanding over the coming years. Film and mesh adhesion barriers are known for their effectiveness in preventing adhesions by physically separating tissues during the healing process. Their versatile nature makes them applicable to various surgical procedures, including those in the cardiovascular, abdominal, gynaecological, and orthopaedic fields. Film and mesh adhesion barriers are typically designed to be easy to handle and apply, which can be beneficial for surgical teams. This ease of use can lead to higher adoption rates among surgeons. If there was a high demand for effective adhesion prevention solutions in various surgical fields, film and mesh barriers might have gained traction due to their versatility.

Application Insights

In 2022, the Global Adhesion Barrier was dominated by cardiovascular surgeries segment and is predicted to continue expanding over the coming years. Cardiovascular diseases are a leading cause of mortality worldwide. The high prevalence of conditions such as coronary artery disease, heart attacks, and heart surgeries could lead to a substantial number of cardiovascular surgeries being performed. Adhesion barriers can be particularly important in cardiovascular surgeries to prevent adhesions around delicate structures like blood vessels and the heart. Cardiovascular surgeries can be complex and delicate procedures involving precise placement of medical devices.  Adhesion barriers can aid in reducing the risk of adhesions that might hinder the healing process or cause complications.


Download Free Sample Report

Regional Insights

The North America region has established itself as the leader in the Global Adhesion Barrier in 2022. This could be attributed to various factors such as advanced healthcare infrastructure, a high volume of surgical procedures, strong research and development capabilities, and a robust regulatory environment. North America, which includes the United States and Canada, has historically been a key hub for medical device innovation and commercialization. The market is dominated by several prominent players, including Johnson & Johnson (J&J), Baxter International, Integra Lifesciences (ILS), FzioMed.

Recent Developments

  • In June 2022, CGBIO a company that specializes in the development of biologic medicinal products, has entered the Indonesian market through the introduction of its fourth-generation solvent-gel type antigens. At room temperature, MEDICLORE exists in the liquid form'sol', and upon application to the skin changes into a highly viscous 'gel' state based on body temperature. This is because MEDICLORE acts as a physical barrier to prevent adhesion in the area it is expected to be applied to after surgery while the wound heals. It can be employed in a variety of surgical procedures, including spinal, joint, and mastectomy operations, as well as in obstetrics and gynaecology, prostatic resection, and gastrointestinal surgery. MEDICLORE is composed of two active ingredients: Poloxamer, which acts as a physical barrier, while Chitosan, which aids in the rapid recovery of tissues without infection due to its antibacterial and haemostatic properties. Poloxamer is responsible for the direct inhibition of adhesion through a temperature dependent change process. Chitosan is responsible for the immediate recovery of tissues.
  • In February 2022, Gunze Limited, a subsidiary of Osaka-Gunze Limited, has been granted medical device approval for the production and sale of TENALAF™, the world's first absorbable sheet-type adhesion barrier manufactured in Japan, which was launched on the Japanese market in March 2022 through its subsidiary "Gunze Medical Japan". Gunze’s absorbable adhesive barrier was developed with the aim of providing a cutting-edge solution in the field of adhesion. The absorbable barrier was developed through the application of proprietary absorbable technology to the absorbable material. This device offers surgeons a novel solution during open or minimally invasive surgeries, which facilitates easy manipulation, offers moderate adhesive strength to reposition, and can be placed in a conformable position. Gunze is committed to increasing its recognition by communicating the new product characteristics and advantages to surgeons and to their patients.
  • In 2020, Johnson & Johnson Medical Devices Companies announced that Ethicon, has been granted 510(c) clearance by the United States Food and Drug administration (FDA). This clearance is granted to Ethicon for the development and commercialization of a novel, airless spray device (VISTASEAL) that combines biologic components with device technology for the treatment of mild-to-moderate surgical bleeding. This device is designed to be used in the open or laparoscopic setting and is composed of two Dual Applicators, one measuring 35 cm and one measuring 45 cm.

Key Market Players

·              Vendor Landscape

·              Medtronic Plc

·              Johnson & Johnson SA

·              Sanofi SA

·              Baxter International Inc.,

·              Becton Dickinson and Company

·              Integra LifeSciences Holdings Corporation

·              Atrium Medical Corporation

·              FzioMed Inc.

·              Mast Biosurgery AG

 By Product

By Formulation

By Application

By Region

•       Synthetic Adhesion Barriers

•       Natural Adhesion Barriers

•       Film/Mesh

•       Gel

•       Liquid

 

•       Gynecological surgeries

•       Abdominal general surgeries

•       Orthopedic surgeries

•       Cardiovascular surgeries

•       Neurological surgeries

•       Urological surgeries

•       others

 

•       Asia Pacific

•       North America

•       Europe

•       Middle East & Africa

•       South America

 

Report Scope:

In this report, the Global Adhesion Barrier Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Adhesion Barrier Market, By Product:

o   Synthetic Adhesion Barriers

§  Hyaluronic acid

§  Regenerated cellulose

§  Polyethylene glycol

§  Others

o   Natural Adhesion Barriers

§  Collagen & Protein

§  Fibrin

  •  Adhesion Barrier Market, By Formulation:

o   Film/Mesh

o   Gel

o   Liquid

  • Adhesion Barrier Market, By Application:

o   Gynecological surgeries

o   Abdominal general surgeries

o   Orthopedic surgeries

o   Cardiovascular surgeries

o   Neurological surgeries

o   Urological surgeries

o   others

  • Global Adhesion Barrier Market, By region:

o   North America

§  United States

§  Canada

§  Mexico

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Australia

§  Japan

o   Europe

§  Germany

§  France

§  United Kingdom

§  Spain

§  Italy

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Adhesion Barrier Market.

Available Customizations:

Global Adhesion Barrier Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Adhesion Barrier Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Adhesion Barrier Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Product (Synthetic Adhesion Barriers (Hyaluronic acid, Regenerated cellulose, Polyethylene glycol, others), Natural Adhesion Barrier (Collagen & Protein, Fibrin))

5.2.2.  By Formulation (Film/Mesh, Gel, Liquid)

5.2.3.  By Application (Gynecological surgeries, Abdominal general surgeries, Orthopedic surgeries, Cardiovascular surgeries, Neurological surgeries, Urological surgeries, others)

5.2.4.  By Company (2022)

5.2.5.  By Region

5.3.  Market Map

6.    North Adhesion Barrier Market Outlook

6.1.  Market Size & Forecast       

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Product

6.2.2.  By Formulation

6.2.3.  By Application

6.3.  North America: Country Analysis

6.3.1.  United States Adhesion Barrier Market Outlook

6.3.1.1.                Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.                Market Share & Forecast

6.3.1.2.1.           By Product

6.3.1.2.2.           By Formulation

6.3.1.2.3.           By Application

6.3.2.  Mexico Adhesion Barrier Market Outlook

6.3.2.1.                Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.                Market Share & Forecast

6.3.2.2.1.           By Product

6.3.2.2.2.           By Formulation

6.3.2.2.3.           By Application

6.3.3.  Canada Adhesion Barrier Market Outlook

6.3.3.1.                Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.                Market Share & Forecast

6.3.3.2.1.           By Product

6.3.3.2.2.           By Formulation

6.3.3.2.3.           By Application

7.    Europe Adhesion Barrier Market Outlook

7.1.  Market Size & Forecast       

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.    By Product

7.2.2.    By Formulation

7.2.3.    By Application

7.3.  Europe: Country Analysis

7.3.1.  France Adhesion Barrier Market Outlook

7.3.1.1.                Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.                Market Share & Forecast

7.3.1.2.1.           By Product

7.3.1.2.2.           By Formulation

7.3.1.2.3.           By Application

7.3.2.  Germany Adhesion Barrier Market Outlook

7.3.2.1.                Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.                Market Share & Forecast

7.3.2.2.1.           By Product

7.3.2.2.2.           By Formulation

7.3.2.2.3.           By Application

7.3.3.  United Kingdom Adhesion Barrier Market Outlook

7.3.3.1.                Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.                Market Share & Forecast

7.3.3.2.1.           By Product

7.3.3.2.2.           By Formulation

7.3.3.2.3.           By Application

7.3.4.  Italy Adhesion Barrier Market Outlook

7.3.4.1.                Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.                Market Share & Forecast

7.3.4.2.1.           By Product

7.3.4.2.2.           By Formulation

7.3.4.2.3.           By Application

7.3.5.  Spain Adhesion Barrier Market Outlook

7.3.5.1.                Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.                Market Share & Forecast

7.3.5.2.1.           By Product

7.3.5.2.2.           By Formulation

7.3.5.2.3.           By Application

8.    Asia-Pacific Adhesion Barrier Market Outlook

8.1.  Market Size & Forecast       

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.    By Product

8.2.2.    By Formulation

8.2.3.    By Application

8.2.4.  By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.  China Adhesion Barrier Market Outlook

8.3.1.1.                Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.                Market Share & Forecast

8.3.1.2.1.           By Product

8.3.1.2.2.           By Formulation

8.3.1.2.3.           By Application

8.3.2.  India Adhesion Barrier Market Outlook

8.3.2.1.                Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.                Market Share & Forecast

8.3.2.2.1.           By Product

8.3.2.2.2.           By Formulation

8.3.2.2.3.           By Application

8.3.3.  South Korea Adhesion Barrier Market Outlook

8.3.3.1.                Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.                Market Share & Forecast

8.3.3.2.1.           By Product

8.3.3.2.2.           By Formulation

8.3.3.2.3.           By Application

8.3.4.  Japan Adhesion Barrier Market Outlook

8.3.4.1.                Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.                Market Share & Forecast

8.3.4.2.1.           By Product

8.3.4.2.2.           By Formulation

8.3.4.2.3.           By Application

8.3.5.  Australia Adhesion Barrier Market Outlook

8.3.5.1.                Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.                Market Share & Forecast

8.3.5.2.1.           By Product

8.3.5.2.2.           By Formulation

8.3.5.2.3.           By Application

9.    South America Adhesion Barrier Market Outlook

9.1.  Market Size & Forecast       

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.    By Product

9.2.2.    By Formulation

9.2.3.    By Application

9.2.4.  By Country

9.3.  South America: Country Analysis

9.3.1.  Brazil Adhesion Barrier Market Outlook

9.3.1.1.                Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.                Market Share & Forecast

9.3.1.2.1.           By Product

9.3.1.2.2.           By Formulation

9.3.1.2.3.           By Application

9.3.2.  Argentina Adhesion Barrier Market Outlook

9.3.2.1.                Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.                Market Share & Forecast

9.3.2.2.1.           By Product

9.3.2.2.2.           By Formulation

9.3.2.2.3.           By Application

9.3.3.  Colombia Adhesion Barrier Market Outlook

9.3.3.1.                Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.                Market Share & Forecast

9.3.3.2.1.           By Product

9.3.3.2.2.           By Formulation

9.3.3.2.3.           By Application

10. Middle East and Africa Adhesion Barrier Market Outlook

10.1.             Market Size & Forecast        

10.1.1.               By Value

10.2.             Market Share & Forecast

10.2.1. By Product

10.2.2. By Formulation

10.2.3. By Application

10.2.4.               By Country

10.3.             MEA: Country Analysis

10.3.1.               South Africa Adhesion Barrier Market Outlook

10.3.1.1.             Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.             Market Share & Forecast

10.3.1.2.1.         By Product

10.3.1.2.2.         By Formulation

10.3.1.2.3.         By Application

10.3.2.               Saudi Arabia Adhesion Barrier Market Outlook

10.3.2.1.             Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.             Market Share & Forecast

10.3.2.2.1.         By Product

10.3.2.2.2.         By Formulation

10.3.2.2.3.         By Application

10.3.3.               UAE Adhesion Barrier Outlook

10.3.3.1.             Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.             Market Share & Forecast

10.3.3.2.1.         By Product

10.3.3.2.2.         By Formulation

10.3.3.2.3.         By Application

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Developments

12.2.             Product Launches

12.3.             Mergers & Acquisitions

13. PESTLE Analysis

14. Porter’s Five Forces Analysis

14.1.             Competition in the Industry

14.2.             Potential of New Entrants

14.3.             Power of Suppliers

14.4.             Power of Customers

14.5.             Threat of Substitute Product

15. Competitive Landscape

15.1.             Business Overview

15.2.             Company Snapshot

15.3.             Products & Services

15.4.             Financials (In case of listed companies)

15.5.             Recent Developments

15.6.             SWOT Analysis

15.6.1.               Vendor Landscape

15.6.2.               Medtronic Plc

15.6.3.               Johnson & Johnson SA

15.6.4.               Sanofi SA

15.6.5.               Baxter International Inc.,

15.6.6.               Becton Dickinson and Company

15.6.7.               Integra LifeSciences Holdings Corporation

15.6.8.               Atrium Medical Corporation

15.6.9.               FzioMed Inc.

15.6.10.            Mast Biosurgery AG

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Adhesion Barrier Market was estimated to be USD 724.89 million in 2022.

down-arrow

Becton Dickinson and Company, Integra LifeSciences Holdings Corporation, Atrium Medical Corporation, FzioMed Inc., Mast Biosurgery AG are some of the key players operating in the Global Adhesion Barrier Market.

down-arrow

Medical device regulations can be complex and stringent. Obtaining regulatory approvals for new adhesion barrier products or making modifications to existing ones could pose challenges.

down-arrow

The development of new and improved materials for adhesion barriers was a significant trend.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Global Adhesion Barrier Market to grow at a CAGR of 5.54% through 2028

Nov, 2023

Improvements in Healthcare Infrastructure and initiatives taken by the government are the major drivers for the Global Adhesion Barrier Market.

Why Choose Us